Membranous Nephropathy Market Therapies: The Dawn of Complement System Inhibitors and Precision Medicine.
Targeting the Downstream Mechanisms of Autoimmune Damage
While current therapies for Membranous Nephropathy (MN) primarily focus on eliminating the B-cells that produce the initial antibodies (like anti-PLA2R), a promising new class of drugs is focused on neutralizing the damage mechanism itself: the complement cascade. The complement system is a crucial part of the innate immune response, but...
0 Commentaires
0 Parts
139 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt